Energy Efficiency, GHG Emissions, Industrial  -  December 5, 2024

Granules’ Goals Validated by SBTi

Granules India Limited, a global pharmaceutical company, received validation and approval from the Science Based Targets initiative (SBTi) for its near-term, long-term and net-zero goals. 

The company committed to achieving net-zero GHG emissions across its value chain including all subsidiaries by FY2050. In the near term, the company targets a 42% reduction in absolute Scope 1 and 2 emissions and Scope 3 emissions by FY2030, using FY2023 as the baseline, alongside transitioning to 100% renewable electricity. 

These near-term and long-term targets are aligned with the 1.5°C pathway, emphasizing Granules' dedication to climate action and achieving net zero well before FY2050. 

"Sustainability lies at the core of our decision-making and business strategy, as articulated in our purpose statement: healing lives responsibly through pioneering green science,” said Krishna Prasad Chigurupati, chairman and managing director of Granules Limited, in a statement. I am proud that Granules has received SBTi validation and approval for our near-term and long-term goals, aligned with the 1.5°C pathway toward net-zero by 2050 or sooner. This milestone strengthens our commitment to accelerate decarbonization, integrate these targets across our operations and supply chain, and drive progress through collaboration and innovation."